Fisetin and Multiple Sclerosis: What PubMed Studies Show

By Insight Swarm Research Team, Medical Advisor: Nikhil Joshi, MD, FRCPC

Fisetin and Multiple Sclerosis: What PubMed Studies Show

PubMed is the primary database of biomedical literature maintained by the National Library of Medicine. This page describes what PubMed-indexed research reveals about Fisetin in the context of Multiple Sclerosis. This is a research summary — not medical advice. Consult your neurologist.

Volume of Available Research

As of 2026, PubMed contains dozens of relevant publications when searching for "Fisetin" combined with "Multiple Sclerosis". The current evidence level derived from this literature is: Preclinical senolytic data very strong; Mayo Clinic SToMP-AD trial ongoing; limited human data

Types of Studies Available

Given the scientific interest in this combination, the published literature includes a range of study types:

  • In vitro (cell culture) studies: Laboratory investigations of Fisetin effects on MS-relevant cell lines
  • In vivo (animal) studies: Preclinical models examining effects on disease pathways
  • Review articles: Systematic reviews and meta-analyses synthesizing available evidence
  • Clinical studies: Human data from case reports, cohort studies, or clinical trials

How to Search PubMed Yourself

To find the most current and complete literature, use these PubMed search strategies:

  • Basic search: Fisetin Multiple Sclerosis
  • Advanced search: (Fisetin[Title/Abstract]) AND (Multiple Sclerosis[Title/Abstract])
  • Filter by article type: Select "Clinical Trial" to focus on human studies
  • Sort by: Most Recent to see latest publications

Interpreting PubMed Results

When reviewing PubMed studies for Fisetin and MS, key considerations include:

  • Study design hierarchy: RCTs > cohort studies > case-control > case reports > animal studies > cell culture
  • Sample size: Small studies (n<50) should be interpreted cautiously
  • Conflict of interest: Check funding sources
  • Replication: Single studies should not change treatment decisions

Medical Disclaimer: This page summarizes published research and is not medical advice. Never start, stop, or change any treatment based on information found online. Always consult qualified healthcare professionals before making treatment decisions.

Get a personalized AI-generated research report at insightswarm.ai.

Frequently Asked Questions

How many PubMed studies exist on Fisetin for MS?

The exact count changes as new research is published. Search pubmed.ncbi.nlm.nih.gov for 'Fisetin AND Multiple Sclerosis' to get the current count. The evidence level from available literature is: Preclinical senolytic data very strong; Mayo Clinic SToMP-AD trial ongoing; limited human data.

Are there PubMed clinical trial results for Fisetin in MS?

To find clinical trial publications: go to PubMed, search 'Fisetin MS', then use the 'Article type' filter to select 'Clinical Trial'. Some clinical data exists for this combination.

Can I access the full text of Fisetin + MS studies for free?

Many NIH-funded studies are available free via PubMed Central (PMC). For paywalled articles, try: the author's institution page, ResearchGate, or emailing the corresponding author directly. Some patients also access papers through their hospital library or university networks.